{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:59:13Z","timestamp":1783511953250,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF16OC0018658"],"award-info":[{"award-number":["NNF16OC0018658"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18OC0031258"],"award-info":[{"award-number":["NNF18OC0031258"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijcard.2021.02.057","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T04:25:49Z","timestamp":1614399949000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study"],"prefix":"10.1016","volume":"333","author":[{"given":"Mikkel","family":"Giehm-Reese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Nyg\u00e5rd","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Brix","family":"Kronborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Kj\u00e6rulf","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Karl","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mogens Stig","family":"Djurhuus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Steen","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcard.2021.02.057_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2021.02.057_bb0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","volume":"41","author":"Brugada","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0015","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillationDeveloped with the special contribution of the European heart rhythm association","volume":"33","author":"Members","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0020","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The optimal anti-coagulation for enhanced-risk patients post\u2013catheter ablation for atrial fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0030","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jce.14052","article-title":"Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: a systematic review and meta-analysis","volume":"30","author":"Romero","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jamacardio.2016.4179","article-title":"Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation","volume":"2","author":"Sj\u00e4lander","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/jce.13822","article-title":"Anticoagulation after catheter ablation of atrial fibrillation: an unnecessary evil? A systematic review and meta-analysis","volume":"30","author":"Proietti","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0045","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.hrthm.2012.07.013","article-title":"Risk of stroke and atrial fibrillation after radiofrequency catheter ablation of typical atrial flutter","volume":"9","author":"Tomson","year":"2012","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00392-014-0682-6","article-title":"Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter","volume":"103","author":"Seara","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0055","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.hrthm.2014.06.038","article-title":"Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter","volume":"11","author":"Voight","year":"2014","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0060","first-page":"838","article-title":"Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study","volume":"19","author":"Vadmann","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2021.02.057_bb0065","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/europace\/euw402","article-title":"Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society","volume":"18","author":"Glover","year":"2017","journal-title":"EP Europace"},{"key":"10.1016\/j.ijcard.2021.02.057_bb0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: the Danish National Database of reimbursed prescriptions","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2019.07.077","article-title":"Recurrent atrial flutter ablation and incidence of atrial fibrillation ablation after first-time ablation for typical atrial flutter: a nation-wide Danish cohort study","volume":"298","author":"Giehm-Reese","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00392-014-0742-y","article-title":"Adherence to warfarin treatment among patients with atrial fibrillation","volume":"103","author":"Skeppholm","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14017431.2017.1304570","article-title":"Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter","volume":"51","author":"De Bortoli","year":"2017","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2018.06.065","article-title":"Outcomes among patients with atrial fibrillation and appropriate anticoagulation control","volume":"72","author":"Bonde","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/europace\/euz235","article-title":"The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese atrial fibrillation registry study","volume":"22","author":"Yang","year":"2020","journal-title":"EP Europace"},{"key":"10.1016\/j.ijcard.2021.02.057_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0120","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3349\/ymj.2018.59.2.236","article-title":"CHA2DS2-VASc score in the prediction of ischemic stroke in patients after radiofrequency catheter ablation of typical atrial flutter","volume":"59","author":"Jin","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0941","article-title":"Comparison of clinical outcomes among patients with atrial fibrillation or atrial flutter stratified by CHA2DS2-Vasc score","volume":"1","author":"Lin","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijcard.2021.02.057_bb0145","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1038\/s41598-019-43566-z","article-title":"Risk factors for ischemic stroke in atrial fibrillation patients undergoing radiofrequency catheter ablation","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0150","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/heartjnl-2019-315873","article-title":"Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk","volume":"106","author":"Verbrugge","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2021.02.057_bb0155","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0165","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0170","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.jacc.2015.09.024","article-title":"Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial","volume":"66","author":"Sherwood","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bcpt.12610","article-title":"Validity of the prescriber information in the Danish national prescription registry","volume":"119","author":"Rasmussen","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2021.02.057_bb0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bcpt.13024","article-title":"Use of non-vitamin K antagonist oral anticoagulants 2008\u20132016: a Danish nationwide cohort study","volume":"123","author":"Haastrup","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0190","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.amjcard.2017.01.041","article-title":"Socioeconomic status as a predictor of mortality in patients admitted with atrial fibrillation","volume":"119","author":"Kargoli","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S132628","article-title":"Positive predictive value of peptic ulcer diagnosis codes in the Danish national patient registry","volume":"9","author":"Viborg","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0200","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CLEP.S167576","article-title":"Intracerebral hemorrhage: positive predictive value of diagnosis codes in two nationwide Danish registries","volume":"10","author":"Hald","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2021.02.057_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaa365","article-title":"Long-term oral anticoagulant after catheter ablation for atrial fibrillation","author":"Chew","year":"2021","journal-title":"EP Europace"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321003661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321003661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:52:47Z","timestamp":1759092767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321003661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"alternative-id":["S0167527321003661"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.057","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}